Asian markets look to rise on vaccine, stimulus hopes

Asian markets were set to rise Wednesday as investors tracked positive news on COVID-19 vaccines and ongoing efforts to launch more fiscal stimulus.

A man wearing a protective face mask walks past a stock quotation board outside a brokerage, amid t
FILE PHOTO: A man wearing a protective face mask walks past a stock quotation board outside a brokerage, amid the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan November 2, 2020. REUTERS/Issei Kato

REUTERS: Asian markets were set to rise Wednesday as investors tracked positive news on COVID-19 vaccines and ongoing efforts to launch more fiscal stimulus.

Australian S&P/ASX 200 futures were up 0.57per cent in early trading, while Japan's Nikkei 225 were down 0.02per cent.

Hong Kong's Hang Seng index futures were up 0.42per cent.

On Wall Street, stocks notched new record levels Tuesday at the S&P and Nasdaq, boosted by gains in the healthcare sector on the back of positive vaccine news and seeming progress on U.S. stimulus talks, as the U.S. dollar dipped.

The Dow Jones Industrial Average rose 0.35per cent, the S&P 500 gained 0.28per cent and the Nasdaq Composite added 0.5per cent.

MSCI's gauge of stocks across the globe gained 0.21per cent. The dollar index was up 0.08per cent.

"USD consolidated amid a lift in U.S. equities to record highs and positive signs that an agreement on an one‑week stopgap funding bill that would push off a partial government shutdown," wrote Joseph Capurso, a strategist with Commonwealth Bank of Australia.

"There appears to be some bipartisan support for a fiscal package of USUS$908 bln (4per cent of GDP)."

U.S. policymakers continued to negotiate over additional stimulus to help offset the economic impact of the pandemic while pursuing a stopgap government funding bill. Leaders in both parties remain adamant a deal must be struck but are still working through sticking points, including aid to state and local governments and business liability protections.

The steady march of positive news on COVID-19 vaccines helped lift investor spirits.

Britain on Tuesday became the first Western nation to begin a wide vaccination campaign, and Johnson & Johnson reported it could obtain late-stage trial results for a single-dose vaccine in January, earlier than expected. Meanwhile, Pfizer Inc cleared another hurdle when the U.S. health regulator released documents flagging no new safety or efficacy concerns.

But the looming prospect of a "no deal" Brexit weighed on investors, as British and European Union negotiators are still trying to break a deadlock in trade deal talks within three weeks.

In the foreign exchange market, sterling was trading down 0.2per cent.

The benchmark 10-year yield was down 1.3 basis points in afternoon trading at 0.9146per cent.

Oil prices were near unchanged, with Brent crude futures settling at US$48.84 a barrel, up 5 cents. U.S. West Texas Intermediate crude futures settled 16 cents lower at US$45.60. Spot gold prices were higher.

(Reporting by Pete Schroeder; Editing by Stephen Coates)

Source: Reuters